- Home
- IMCR vs WT Comparison
IMCR vs WT Comparison
Compare IMCR & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- WT
- Stock Information
- Founded
- IMCR 2008
- WT 1985
- Country
- IMCR United Kingdom
- WT United States
- Employees
- IMCR N/A
- WT N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- WT Investment Bankers/Brokers/Service
- Sector
- IMCR Health Care
- WT Finance
- Exchange
- IMCR Nasdaq
- WT Nasdaq
- Market Cap
- IMCR 1.5B
- WT 1.5B
- IPO Year
- IMCR 2021
- WT N/A
- Fundamental
- Price
- IMCR $31.34
- WT $10.36
- Analyst Decision
- IMCR Buy
- WT Buy
- Analyst Count
- IMCR 10
- WT 7
- Target Price
- IMCR $58.13
- WT $12.36
- AVG Volume (30 Days)
- IMCR 560.7K
- WT 1.3M
- Earning Date
- IMCR 08-07-2025
- WT 07-25-2025
- Dividend Yield
- IMCR N/A
- WT 1.16%
- EPS Growth
- IMCR N/A
- WT N/A
- EPS
- IMCR N/A
- WT 0.37
- Revenue
- IMCR $333,581,000.00
- WT $438,981,000.00
- Revenue This Year
- IMCR $26.82
- WT $7.75
- Revenue Next Year
- IMCR $8.15
- WT $5.78
- P/E Ratio
- IMCR N/A
- WT $28.23
- Revenue Growth
- IMCR 25.75
- WT 20.66
- 52 Week Low
- IMCR $23.15
- WT $7.47
- 52 Week High
- IMCR $41.54
- WT $12.45
- Technical
- Relative Strength Index (RSI)
- IMCR 40.28
- WT 64.73
- Support Level
- IMCR $35.10
- WT $10.10
- Resistance Level
- IMCR $37.56
- WT $10.41
- Average True Range (ATR)
- IMCR 1.74
- WT 0.23
- MACD
- IMCR -0.79
- WT 0.02
- Stochastic Oscillator
- IMCR 0.75
- WT 92.13
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.